Statin (3-Hydroxy-3-Methylglutaryl-Coenzyme a Reductase Inhibitor)-Based Therapy for Hepatitis C Virus (HCV) Infection-Related Diseases in the Era of Direct-Acting Antiviral Agents
F1000Research - United Kingdom
doi 10.12688/f1000research.7970.3
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 25, 2017
Authors
Publisher
F1000 Research Ltd